Israel
Wizermed, established in 2023 and headquartered in Israel, is carving a niche in the AI and Digital Health sectors, with a specific focus on migraine management. Their mobile application, Migraine Predict, offers targeted solutions to improve the quality of life for migraine sufferers. By leveraging smartwatch data, the app uses AI to predict the likelihood of a migraine attack the following day, enabling proactive planning and symptom management.
The app's innovative approach addresses not only the physical impacts of migraines but also the emotional and social consequences associated with their unpredictability. Through predictive insights, Wizermed empowers users to make informed decisions about their daily activities and social commitments, potentially enhancing both personal and professional life quality.
Bolstered by an $800.00K seed investment received in August 2023, Wizermed is poised to expand its reach in the health care industry, providing wise solutions for migraine management.
